Jump to content

Moderna’s share price on watch ahead of Q3 earnings


MongiIG

Recommended Posts

Moderna’s share price is down close to 40% year-to-date, as Covid-19 risks took a backseat. What can we look forward to in the upcoming Q3 results?

ModernaSource: Bloomberg
 
 Yeap Jun Rong | Market Strategist, Singapore | Publication date: Wednesday 02 November 2022

When does Moderna report earnings?

Moderna is set to release its third-quarter (Q3) financial results on 3 November 2022, before market open. Current expectations are for its Q3 revenue to fall 29.0% from a year ago at US$3.5 billion. This will also mark the third consecutive quarterly decline. Earnings per share (EPS) is expected to come in at $3.29, a 57.2% decline from a year ago.

Still seeking a catalyst after Covid-19

With Moderna previously riding on the Covid-19 waves, abating virus risks in its key markets such as US and Europe have driven an ongoing moderation in its profits since its peak in Q4 2021. More than 70% of the total population in US and Europe has already been fully vaccinated and that leaves Moderna having to seek vaccine sales outside of those regions. That has not played out well thus far, with Moderna’s second-quarter (Q2) revenue outside of US and Europe contracting by 42% quarter-on-quarter. Lower-priced vaccine alternatives, the relative strength of the US dollar and less emphasis on vaccination with economic reopening could be reasons for the low take-up rate.

The emergence of new Covid-19 sub-variants such as BQ.1 and BQ1.1 may call for the need for updated vaccine booster shots, but unless new sub-variants proved to be significantly more deadly and more resistant to currently available vaccines, the take-up rate for additional booster shots could still be lukewarm. Addressable market size could be more dependent on the elderly population and even then, it will have to take much more to convince markets that its growth can be sustainable. To top it off, the US government has announced to stop buying Covid-19 vaccines as early as this November and will remove the free distribution of Covid-19 shots starting next year, leaving Covid-19 product manufacturers to compete in the private markets.

Chart 1: Share of people vaccinated against Covid-19Source: Our World in Data

 

Pressure is on for other new innovative commercial developments

The pressure is clearly on for Moderna to diversify away from Covid-19 vaccines, which it is currently still heavily dependent on. A key unique selling point for the success of Moderna’s vaccines against Covid-19 is its mRNA technology, which has the potential to be replicated to develop other forms of vaccines. The company is currently in the midst of developing a deal with the US government to develop vaccines against a range of biological threats, including Ebola. Pharmaceutical giant, Merck & Co, has also paid Moderna US$250 million to co-develop a vaccine for returning skin cancer. With its overseas operations revolving around research in other vaccine developments for infectious diseases, cancer and rare disease, further tie-up and collaboration could be in the pipeline.

That said, as with all forms of research and development efforts, it comes with prolonged expenses, risks of failure and could take years to materialise (and monetize). The US$7.9 billion cash pool in the company does provide some runway for Moderna to tap on, but if a trend is formed for a constant drawdown (as with past two quarters), that could still drive some caution.

Technical analysis: Breakout of ranging pattern may be needed

Moderna’s share price has been largely trading in a ranging pattern since the start of the year, with the flat-lined moving average convergence/divergence (MACD) revealing an ongoing period of indecision. A clear catalyst to drive further moves could be much needed, as trading volume has not been heading lower ever since hitting its peak in August 2021. Trading within the range will leave near-term support at the US$116.00 level, while resistance could be presented at the upper consolidation range at the US$200.00 level. It may seem that a move above the US$200.00 level could be necessary to indicate a trend reversal and open the path to the US$263.00 level next.

Moderna daily chartSource: IG Charts

On the lower four-hour timeframe, Moderna’s share price is currently finding resistance at the US$148.00 level, with a bearish rejection presented in the formation of a shooting star candle. Overcoming this level could drive a retest of the US$158.40 level of resistance next.

Moderna 4 hour chartSource: IG Charts
Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • image.png

  • Posts

    • Gold Elliott Wave Analysis Function - Counter-Trend Mode - Corrective Structure - Likely Double Zigzag Position -Wave 4 Direction - Wave 4 is still in play Details - Gold count adjusted to fit the sideways structure emerging for wave 4. The structure still supports further rallies. Gold has remained in a sideways range since the decline on April 12th, 2024. Despite this consolidation, the metal is poised for more gains and potentially a fresh all-time high. Gold is in a long-term bullish trend, with no significant bearish correction expected until the impulse cycle from September 2023 completes.   Daily Chart Analysis: Gold prices have been largely bullish, with a cycle degree impulse wave III emerging from 1810.5 in September 2023. Currently, the price is in a minor degree wave 4, which initially appeared to be a zigzag structure. However, the sustained sideways price action suggests this is a triangle structure for wave 4. Before the eventual breakout to the upside, Gold might make one more leg lower within the range. The goal now is wave 5.   H4 Chart Analysis: The H4 chart shows the sub-waves of the emerging triangle structure, which is currently on the fourth leg - wave d (circled). Wave e (circled) should follow, but it should stay above 2286 to avoid invalidating the triangle structure. Thus, the invalidation level for this setup is 2286. Provided the price remains above that level, the potential for more upside is far greater. Wave 5 should reach at least the 2500 key psychological level.   Summary: Gold has been in a sideways range since the decline on April 12th, 2024, but is expected to make further gains and potentially reach a new all-time high. The long-term trend is bullish, with no significant bearish correction expected until the impulse cycle from September 2023 ends. On the daily chart, Gold is in a cycle degree impulse wave III from 1810.5, with the current minor degree wave 4 forming a triangle structure.   On the H4 chart, wave d (circled) of the triangle is in progress, with wave e (circled) expected next. The triangle structure remains valid as long as the price stays above 2286. If this level holds, the potential for more upside increases, with wave 5 likely to reach at least the 2500 level. Technical Analyst : Sanmi Adeagbo Source : Tradinglounge.com get trial here!  
    • AVY Elliott Wave Analysis Trading Lounge Daily Chart, Avery Dennison Corp., (AVY) Daily Chart AVY Elliott Wave Technical Analysis FUNCTION: Trend MODE: Impulsive STRUCTURE: Motive POSITION: Wave {iii} of 5.   DIRECTION: Upside in wave {iii}. DETAILS: Looking for upside into wave 5, equality of 5 vs. 3 which in this case will stand as invalidation level, as wave 3 is currently shorter than 1, stands at 250$.     AVY Elliott Wave Analysis Trading Lounge 4Hr Chart, Avery Dennison Corp., (AVY) 4Hr Chart AVY Elliott Wave Technical Analysis FUNCTION: Trend MODE: Impulsive STRUCTURE: Motive POSITION: Wave (ii) of {iii}.   DIRECTION: Upside {iii}. DETAILS: Looking for minute wave {iii} to start unfolding, otherwise we could be in either a top in place, or else we could be forming an ending diagonal in wave 5.   Welcome to our latest Elliott Wave analysis for Avery Dennison Corp. (AVY). This analysis provides an in-depth look at AVY's price movements using the Elliott Wave Theory, helping traders identify potential opportunities based on current trends and market structure. We will cover insights from both the daily and 4-hour charts to offer a comprehensive perspective on AVY's market behavior.   * AVY Elliott Wave Technical Analysis – Daily Chart* In our Elliott Wave analysis of Avery Dennison Corp. (AVY), we observe an impulsive trend pattern characterized by a motive structure. AVY is currently positioned in wave {iii} of 5, indicating a continuation higher within this wave sequence. The target level for the upside movement into wave 5 is the equality of wave 5 vs. wave 3, which stands at the $250 level. This target also acts as the invalidation level, as wave 3 is currently shorter than wave 1. Traders should monitor this level closely as it provides a critical threshold for potential wave completion and validation of the current wave structure.   * AVY Elliott Wave Technical Analysis – 4Hr Chart* On the 4-hour chart, AVY continues to follow an impulsive trend mode within a motive structure, specifically in wave (ii) of {iii}. The current analysis suggests an anticipated unfolding of minute wave {iii}, which would indicate further upside potential. However, if this wave does not start unfolding as expected, it could suggest that a top might already be in place, or alternatively, we could be forming an ending diagonal in wave 5.   This potential scenario should be watched for confirmation or invalidation to adapt trading strategies accordingly.   Technical Analyst : Alessio Barretta Source : Tradinglounge.com get trial here!  
    • Asian shares are ending the week lower after recent rallies. Yesterday on Wall Street the Dow made gains while Nvidia and other tech names came under short-term pressure. The dollar continues to strengthen, pushing the Japanese yen close to levels last seen in April, which then provoked a currency intervention. European markets are expected to open flat, while US futures show slight gains. The MSCI Asia-Pacific index fell 0.6%, led by a pullback in technology stocks. Japan's inflation slowed in May, complicating the outlook for interest rate hikes. Currency markets saw the euro, sterling, and Swiss franc fall against the US dollar. Today is dominated by flash PMIs from around the globe, including Germany, the UK and the US. 
×
×
  • Create New...
us